Cargando…

COVID-19: The Need for Immunoprevention at Industrial Scale

Detalles Bibliográficos
Autor principal:	Halstead, Scott B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253134/ https://www.ncbi.nlm.nih.gov/pubmed/32274985 http://dx.doi.org/10.4269/ajtmh.20-0239

Ejemplares similares

An Urgent Need for “Common Cold Units” to Study COVID-19
por: Halstead, Scott B.
Publicado: (2020)

Immunoprevention approaches for cancer prevention
por: Umar, Asad
Publicado: (2014)

Cancer Immunoprevention and Public Health
por: Singh, Sandeep K., et al.
Publicado: (2017)

Costs related to immunopreventable diseases: Brazil and its geographic areas (immunopreventable diseases’ costs in Brazil)
por: da Costa, Élide Sbardellotto M., et al.
Publicado: (2021)

An Overview of Cancer Prevention: Chemoprevention and Immunoprevention
por: Gu, Kyle J., et al.
Publicado: (2020)

Moving Immunoprevention Beyond Virally Mediated Malignancies: Do We Need to Link It to Early Detection?
por: Dhodapkar, Madhav V., et al.
Publicado: (2019)

Modelling vaccination schedules for a cancer immunoprevention vaccine
por: Motta, Santo, et al.
Publicado: (2005)

Cancer immunoprevention: from mice to early clinical trials
por: Palladini, Arianna, et al.
Publicado: (2018)

Vaccines for immunoprevention of DNA mismatch repair deficient cancers
por: Hernandez-Sanchez, Alejandro, et al.
Publicado: (2022)

Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review
por: Koyande, Navami Prabhakar, et al.
Publicado: (2022)

Immunoprevention of Basal Cell Carcinomas with Recombinant Hedgehog-interacting Protein
por: Vogt, Annika, et al.
Publicado: (2004)

Health Disparities in the Immunoprevention of Human Papillomavirus Infection and Associated Malignancies
por: Bakir, Amira H., et al.
Publicado: (2015)

Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine
por: Pan, Jing, et al.
Publicado: (2017)

Hospital costs of immunopreventable diseases in the economically active population in Brazil
por: da Costa, Élide Sbardellotto M., et al.
Publicado: (2021)

Vaccination-Based Immunoprevention of Colorectal Tumors: A Primer for the Clinician
por: Jackson, Katy, et al.
Publicado: (2022)

Precision and Immunoprevention Strategies for Tobacco-Related Head and Neck Cancer Chemoprevention
por: Centuori, Sara M., et al.
Publicado: (2021)

Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR‐Driven Lung Cancer
por: Huang, Mofei, et al.
Publicado: (2022)

Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches
por: Emran, Talha Bin, et al.
Publicado: (2022)

Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies
por: Sei, Shizuko, et al.
Publicado: (2023)

A Novel Anti-PD-L1 Vaccine for Cancer Immunotherapy and Immunoprevention
por: Chen, Jie, et al.
Publicado: (2019)

Toxoplasma Rhoptries: Unique Secretory Organelles and Source of Promising Vaccine Proteins for Immunoprevention of Toxoplasmosis
por: Dlugonska, Henryka
Publicado: (2008)

Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis
por: Croci, Stefania, et al.
Publicado: (2015)

Targeting IL-1β as an immunopreventive and therapeutic modality for K-ras–mutant lung cancer
por: Yuan, Bo, et al.
Publicado: (2022)

Construction industry: More needs to be done
por: Kulkarni, G. K.
Publicado: (2007)

Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper
por: Driggers, Lara, et al.
Publicado: (2009)

Targeted Vaccination against Human α-Lactalbumin for Immunotherapy and Primary Immunoprevention of Triple Negative Breast Cancer
por: Tuohy, Vincent K., et al.
Publicado: (2016)

Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention
por: Lee, Sang Beom, et al.
Publicado: (2023)

What We Need to Prepare for the Fourth Industrial Revolution
por: Yoon, Dukyong
Publicado: (2017)

The need for geriatric scales in glioblastoma
por: Domenech, Marta, et al.
Publicado: (2021)

Challenges to the Design of Clinical Trials for Live-Attenuated Tetravalent Dengue Vaccines
por: Russell, Philip K., et al.
Publicado: (2016)

“COVID-19 and its Impact on GSJ & the Publishing Industry”
por: Wang, Jeffrey C., et al.
Publicado: (2022)

Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancer
por: Annapragada, Ananth, et al.
Publicado: (2020)

Influenza, Like COVID-19, Needs Randomized Trials
por: Rothberg, Michael B.
Publicado: (2021)

Covid-19: need for technological independence
por: Ospina Ramirez, Martha Lucia
Publicado: (2020)

Recovery of Waste Materials: Technological Research and Industrial Scale-Up
por: Medici, Franco
Publicado: (2022)

Medical Guidelines and Performance Measures: The Need to Keep Them Free of Industry Influence
por: Eichacker, Peter Q., et al.
Publicado: (2008)

OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis
por: Nanni, Patrizia, et al.
Publicado: (2018)

Epithelial Mutant p53 Promotes Resistance to Anti-PD-1-Mediated Oral Cancer Immunoprevention in Carcinogen-Induced Mouse Models
por: Wang, Jin, et al.
Publicado: (2021)

COVID-19 and school return: The need and necessity
por: Betz, Cecily L.
Publicado: (2020)

The COVID-19 pandemic. Resilience and new needs?
por: de Souza, Maria do Carmo Borges, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_379q3s68cmun1d5bphrh76p7tp